WHO warns of widespread resistance to common antibiotics worldwide
On Oct. 13, 2025, the World Health Organization (WHO) reported that one in six laboratory-confirmed bacterial infections causing…
-
-
New Study Reveals Widespread Drug Resistance Across 14 African Countries
On Jul. 23, 2025, results from a newly published study highlight the growing spread of drug resistance across…
-
GSK’s Blujepa (gepotidacin) approved by U.S. FDA for treatment of uncomplicated urinary tract infections
On Mar. 25, 2025, GSK announced that the US Food and Drug Administration (FDA) has approved Blujepa (gepotidacin)…
-
Cumberland Pharma Announced Initiative To Expand Availability Of VIBATIV® To Treat Hospital-Acquired & Ventilator-Associated Pneumonia Resulting From Coronavirus Infections
On Mar. 23, 2020, Cumberland Pharmaceuticals announced a national initiative to support the treatment of patients with hospital-acquired and…
